Lazar David E.

CIK 000193284312 companiesPANAMA CITY

SEC Profile

Transactions

Companies

Filings

CIK

0001932843

Recent Transactions

50 trades

Award
Aterian, Inc.$ATER
Series AA Convertible Non-Redeemable Preferred Stock
2026-04-27+1,750,000→ 1,750,000 total
Award
Quantum Cyber N.V.$QUCY
Series E Preferred Shares
2026-04-22$1.50/sh+1,000,000→ 1,000,000 total
Award
Quantum Cyber N.V.$QUCY
Series D Preferred Shares
2026-04-22$1.50/sh+1,000,000→ 1,000,000 total
Award
Sow Good Inc.$SOWG
Common Stock
2026-03-31$0.14/sh+5,740,000→ 5,740,000 total
Sale
Indaptus Therapeutics, Inc.$INDP
Series AAA Convertible Non-Redeemable Preferred Stock
2026-03-23−700,000→ 0 total
Sale
Indaptus Therapeutics, Inc.$INDP
Series AA Convertible Non-Redeemable Preferred Stock
2026-03-23−196,800→ 103,200 total
Award
Quantum Cyber N.V.$QUCY
Series B Preferred Shares
2026-02-13+1,000,000→ 1,000,000 total
Award
Quantum Cyber N.V.$QUCY
Series C Preferred Shares
2026-02-13+1,000,000→ 1,000,000 total
Award
Quantum Cyber N.V.$QUCY
Series A Preferred Shares
2026-02-13+1,000,000→ 1,000,000 total
Award
Sow Good Inc.$SOWG
Series AA Preferred Stock
2025-12-31$2.00/sh+1,500,000→ 1,500,000 total
Exercise/Conversion
Sow Good Inc.$SOWG
Series AA Preferred Stock
2025-12-31$2.00/sh−410,000→ 1,090,000 total
Other
KALA BIO, Inc.$KALA
Convertible Loan
2025-12-18−368,614→ 0 total
Award
KALA BIO, Inc.$KALA
Series AA Convertible Preferred Stock
2025-11-24+900,000→ 900,000 total
Exercise/Conversion
Stablecoin Development Corp$SDEV
Series D Convertible Preferred Stock
2025-10-21−39,925→ 0 total
Award
Stablecoin Development Corp$SDEV
Common Stock
2025-10-21+6,388,000→ 6,388,000 total
Sale
Stablecoin Development Corp$SDEV
Series D Convertible Preferred Stock
2025-10-16−441,325→ 39,925 total
Sale
Bio Green Med Solution, Inc.$BGMS
Common Stock
2025-07-30$12.36/sh−6,750→ 155,838 total
Award
LQR House Inc.$YHC
Common Stock
2025-04-02+100,000→ 100,000 total
Exercise/Conversion
Bio Green Med Solution, Inc.$BGMS
Series D Convertible Preferred Stock
2025-02-26−1,745,262→ 354,738 total
Exercise/Conversion
Bio Green Med Solution, Inc.$BGMS
Common Stock
2025-02-26+191,978,820→ 194,628,820 total
Exercise/Conversion
Bio Green Med Solution, Inc.$BGMS
Common Stock
2025-02-26+2,650,000→ 2,650,000 total
Exercise/Conversion
Bio Green Med Solution, Inc.$BGMS
Series C Convertible Preferred Stock
2025-02-26−1,000,000→ 0 total
Sale
Bio Green Med Solution, Inc.$BGMS
Common Stock
2025-02-26$0.03/sh−194,628,820→ 0 total
Sale
FiEE, Inc.$FIEE
Series A Convertible Preferred Stock
2025-02-18−2,219,447→ 85,910 total
Sale
FiEE, Inc.$FIEE
Warrants
2025-02-18−2,800,000→ 0 total
Award
FiEE, Inc.$FIEE
Common Stock
2025-02-18+1,200,000→ 2,681,980 total
Award
Bio Green Med Solution, Inc.$BGMS
Series D Convertible Preferred Stock
2025-02-06+2,100,000→ 2,100,000 total
Purchase
FiEE, Inc.$FIEE
Common Stock
2024-12-26$0.03/sh+1,456,980→ 1,481,980 total
Sale
LQR House Inc.$YHC
Common Stock
2024-11-25−280,000→ 0 total
Sale
LQR House Inc.$YHC
Common Stock
2024-11-21−821,818→ 280,000 total
Award
FiEE, Inc.$FIEE
Series A Convertible Preferred Stock
2024-10-21+305,357→ 2,305,357 total
Sale
CapForce Inc.
Series E Convertible Preferred Stock
2024-07-30−550,000→ 0 total
Purchase
CapForce Inc.
Series E Convertible Preferred Stock
2024-04-23$1.00/sh+150,000→ 550,000 total
Award
CapForce Inc.
Series E Convertible Preferred Stock
2024-04-23$1.00/sh+150,000→ 550,000 total
Award
CapForce Inc.
Common Stock
2024-04-11+100,000→ 100,000 total
Award
CapForce Inc.
Series E Convertible Preferred Stock
2024-04-05$1.00/sh+200,000→ 200,000 total
Purchase
CapForce Inc.
Series E Convertible Preferred Stock
2024-04-05$1.00/sh+200,000→ 9,600,000 total
Purchase
FiEE, Inc.$FIEE
Warrants
2024-01-29+2,800,000→ 2,800,000 total
Purchase
FiEE, Inc.$FIEE
Series A Convertible Preferred Stock
2024-01-29$1.40/sh+2,000,000→ 2,000,000 total
Award
FiEE, Inc.$FIEE
Common Stock
2024-01-22+25,000→ 25,000 total
Award
TITAN PHARMACEUTICALS INC$TTNP
Common Stock
2023-07-26+100,000→ 100,000 total
Sale
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-06-21$1.23/sh−359,066→ 0 total
Sale
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-06-21$1.23/sh−359,066→ 0 total
Sale
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-06-21$1.23/sh−3,388,902→ 0 total
Sale
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-06-21$1.23/sh−3,388,902→ 0 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-01-25$1.00/sh+20,000→ 3,388,902 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2023-01-24$0.97/sh+37,500→ 3,368,902 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2022-07-07$0.99/sh+744,294→ 3,331,402 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2022-07-06$0.89/sh+315,921→ 359,066 total
Purchase
TITAN PHARMACEUTICALS INC$TTNP
Common Stock, par value $0.001
2022-07-06$0.77/sh+1,165,975→ 2,587,108 total

Companies

Recent Filings

Address

44, TOWER 100, THE TOWERS WINSTON CHURCHILL, PAITILLA

PANAMA CITY, 07196

View on SEC.gov